AJP - Heart BIOPAC complete lab solutions
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 290: H2424-H2431, 2006; doi:10.1152/ajpheart.00962.2005
0363-6135/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leshnower, B. G.
Right arrow Articles by Gorman, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leshnower, B. G.
Right arrow Articles by Gorman, R. C.

Role of acetaminophen in acute myocardial infarction

Bradley G. Leshnower,1,* Hiroaki Sakamoto,1,* Ahmad Zeeshan,1 Landi M. Parish,1 Robin Hinmon,1 Theodore Plappert,2 Benjamin M. Jackson,1 Joseph H. Gorman, III,1 and Robert C. Gorman1

1Harrison Department of Surgical Research and 2Division of Cardiology, Department of Medicine, University Pennsylvania School of Medicine, Philadelphia, Pennsylvania

Submitted 8 September 2005 ; accepted in final form 12 January 2006

Acetaminophen, the active ingredient in Tylenol, is a widely used drug that is well known for its analgesic and antipyretic properties. Acetaminophen is a commonly used alternative to nonsteroidal anti-inflammatory drugs, which have recently been demonstrated to increase mortality after acute myocardial infarction (AMI). The safety and potential cardioprotective properties of acetaminophen in the setting of AMI have recently been investigated; however, the results from these studies have been inconclusive. Using both large (ovine) and small (rabbit) collateral-deficient animal models, we studied the effects of acetaminophen in the setting of reperfused AMI. In both species we studied the effects of acetaminophen on myocardial salvage and ventricular function. Additionally, we studied the effects of acetaminophen on myocardial perfusion in sheep and on myocyte apoptosis in rabbits. Sixteen sheep and twenty-two rabbits were divided into two groups and administered acetaminophen or a vehicle before undergoing ischemia and reperfusion. The ischemic period was 60 min in sheep and 30 min in rabbits. All animals were reperfused for 3 h. There were no significant differences observed in myocardial perfusion, myocyte apoptosis, or infarct size in acetaminophen-treated animals. Acetaminophen increased cardiac output and mean arterial pressure before ischemia in sheep but had no effect on any other hemodynamic parameter. In rabbits, no effect on cardiac output or blood pressure was detected. These results support the role of acetaminophen as a safe drug in the postmyocardial infarction setting; however, no significant cardioprotective effect of the drug could be demonstrated.

reperfusion therapy; nonsteroidal anti-inflammatory drugs; sonomicrometry array localization



Address for reprint requests and other correspondence: R. C. Gorman, Harrison Dept. of Surgical Research, Univ. of Pennsylvania School of Medicine, 313 Stemmler Hall, 36th and Hamilton Walk, Philadelphia, PA 19104-4283 (e-mail: gormanr{at}uphs.upenn.edu)




This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
G. F. Merrill, J. H. Merrill, R. Golfetti, K. M. Jaques, N. S. Hadzimichalis, S. S. Baliga, and T. H. Rork
Antiarrhythmic Properties of Acetaminophen in the Dog
Experimental Biology and Medicine, October 1, 2007; 232(9): 1245 - 1252.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. G. Leshnower, H. Sakamoto, H. Hamamoto, A. Zeeshan, J. H. Gorman III, and R. C. Gorman
Progression of myocardial injury during coronary occlusion in the collateral-deficient heart: a non-wavefront phenomenon
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1799 - H1804.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.